Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880425 · ClinicalTrials.gov registry record
Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 45
- Enrollment target
NCT00880425: Completed study, sponsored by Thomas Jefferson University.
NCT00880425 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00880425 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The objective of this study is to determine if patients with chronic daily headache have continuous headache or moments of headache relief. The secondary objective of this study is to determine the period of time patients who have chronic daily headache that is not continuous are headache free.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-07 |
What the finished NCT00880425 record still lists
NCT00880425 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00880425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00880425 about?
NCT00880425 is a clinical study titled "Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?". The objective of this study is to determine if patients with chronic daily headache have continuous headache or moments of headache relief. The secondary objective of this study is to determine the period of time patients who have chronic daily headache that is not continuous are headache free.
What is the current status of trial NCT00880425?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2009-04. Estimated completion is 2009-07.
Who is sponsoring clinical trial NCT00880425?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia